# A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects

> **NCT03014895** · EARLY_PHASE1 · COMPLETED · sponsor: **EA Pharma Co., Ltd.** · enrollment: 29 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Placebo
- **DRUG:** E3112

## Key facts

- **NCT ID:** NCT03014895
- **Lead sponsor:** EA Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-25
- **Primary completion:** 2017-06-12
- **Final completion:** 2017-11-22
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03014895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03014895, "A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03014895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*